SH

Star Health & Allied Insurance Company Ltd

Q4 FY26Insurance

Star Health & Allied Insurance Company Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price573
Market cap₹34.1K Cr
P/E40.3
Updated24 Aug 2026
Read5 min read

What the Q4 FY26 call signalled

1 of 2 strong

RevenueGood growth
MarginMargins steady

The short version

Star Health aims for profitable, sustainable growth rather than just market share expansion. Star Health expects steady growth on an N basis with upwards of 39% growth for FY26. - Profitable growth remains a key focus, targeting profitable geographies and consumer cohorts rather than just market share expansion. - Fresh retail business growth driven by both value and volume, with retail policies expanding by 11% YoY in Q4 FY26. - Continued price increases planned, aligned with product performance and actuarial principles. - Loss ratio improvements expected to sustain due to repricing and better portfolio mix, supporting underwriting profitability. - Normalized profit after tax rose 45% YoY in FY26 to Rs.

From Star Health & Allied Insurance Company Ltd's Q4 FY26 earnings-call transcript · updated 24 Aug 2026.

Revenue & Sales Performance

Good growth
  • Star Health aims for profitable, sustainable growth rather than just market share expansion.
  • Fresh retail growth is expected to remain strong with a focus on value and volume; fresh retail growth was 38% YoY in Q4 FY26.
  • New-to-insurance mix remains high (~94%-95% on fresh premium), targeting new, profitable customer cohorts.
  • Company projects NEP growth of upwards of 39% for FY26 and expects this to improve further with long-term policies accruing in NEP.
  • Growth targets include maintaining a steady state industry growth alignment of 70-80% overall.
  • Focus on profitable geographies and segments like SME with growth targets aligned to organizational objectives.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Star Health & Allied Insurance Company Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The transcript does not explicitly mention specific current or future capex or strategic capital investments. However, relevant points indicating investment focus include: - Continued investment in technology platforms, especially the Medi Assist platform for claims processing, improving efficiency and customer experience. - Ongoing digital investments to enhance productivity, service outcomes, platform modernization, workflow automation, and AI deployment. - Significant investment in agent upskilling and technology-enabled Learning & Development to improve productivity and maintain agent stickiness.

2 more points management made on capital expenditure plans

Top-ranked in Insurance

Ranked on what management guided this quarter

5x potential
1Max Financial
Rev 2Mar 3
2Niva Bupa Health
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 3Mar 3
Sign up free to see 2 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Star Health & Allied Insurance Company Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided pages from the document do not contain specific information regarding the current or expected order book or pending orders. The discussion primarily revolves around: - Loss ratios and underwriting improvements. - Pricing strategies and impact of external environment. - Claims processing and technology platform transition. - Growth strategies in retail and group health segments.

2 more points management made on order book & pipeline

Star Health & Allied Insurance Company Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹4.6K Cr, net profit ₹111 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Insurance this season

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Star Health & Allied Insurance Company Ltd Q4 FY26 results?

Star Health aims for profitable, sustainable growth rather than just market share expansion. Star Health expects steady growth on an N basis with upwards of 39% growth for FY26. - Profitable growth remains a key focus, targeting profitable geographies and consumer cohorts rather than just market share expansion. - Fresh retail business growth driven by both value and volume, with retail policies expanding by 11% YoY in Q4 FY26. - Continued price increases planned, aligned with product performance and actuarial principles. - Loss ratio improvements expected to sustain due to repricing and better portfolio mix, supporting underwriting profitability. - Normalized profit after tax rose 45% YoY in FY26 to Rs.

What is Star Health & Allied Insurance Company Ltd share price analysis?

Star Health & Allied Insurance Company Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 40.3 with a market cap of ₹34,052 Cr. Investors should review the full earnings analysis for detailed insights.

Is Star Health & Allied Insurance Company Ltd planning capital expenditure?

The transcript does not explicitly mention specific current or future capex or strategic capital investments.

Keep Star Health & Allied Insurance Company Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.